AAAAAA
Results:
1-10
|
Results: 10
Authors:
Hassani, OK
Mouroux, M
Bohme, GA
Stutzmann, JM
Feger, J
Citation: Ok. Hassani et al., Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain, MOVEMENT D, 16(6), 2001, pp. 1110-1114
Authors:
Delaugerre, C
Valantin, MA
Mouroux, M
Bonmarchand, M
Carcelain, G
Duvivier, C
Tubiana, R
Simon, A
Bricaire, F
Agut, H
Autran, B
Katlama, C
Calvez, V
Citation: C. Delaugerre et al., Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure, AIDS, 15(16), 2001, pp. 2189-2191
Authors:
Delaugerre, C
Rohban, R
Simon, A
Mouroux, M
Tricot, C
Agher, R
Huraux, JM
Katlama, C
Calvez, V
Citation: C. Delaugerre et al., Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen, J MED VIROL, 65(3), 2001, pp. 445-448
Authors:
Delaugerre, C
Mouroux, M
Yvon-Groussin, A
Simon, A
Angleraud, F
Huraux, JM
Agut, H
Katlama, C
Calvez, V
Citation: C. Delaugerre et al., Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice, ANTIM AG CH, 45(3), 2001, pp. 946-948
Authors:
Burgard, M
Izopet, J
Dumon, B
Tamalet, C
Descamps, D
Ruffault, A
Vabret, A
Bargues, G
Mouroux, M
Pellegrin, I
Ivanoff, S
Guisthau, O
Calvez, V
Seigneurin, JM
Rouzioux, C
Citation: M. Burgard et al., HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment, AIDS RES H, 16(18), 2000, pp. 1939-1947
Authors:
Mouroux, M
Izopet, J
Descamps, D
Delaugerre, C
Yvon-Groussin, A
Angleraud, F
Coutellier, A
Bonmarchand, M
Valantin, MA
Matheron, S
Agut, H
Katlama, C
Brun-Vezinet, F
Calvez, V
Citation: M. Mouroux et al., Conditions of selection of 'thymidine analogue mutations' (TAMs) in naive patients receiving different antiretroviral combinations including d4T., PATH BIOL, 48(5), 2000, pp. 508-512
Authors:
Mouroux, M
Yvon-Groussin, A
Peytavin, G
Delaugerre, C
Legrand, M
Bossi, P
Do, B
Trylesinski, A
Diquet, B
Dohin, E
Delfraissy, JF
Katlama, C
Calvez, V
Citation: M. Mouroux et al., Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial)is not associated with mutations conferring viral resistance, J CLIN MICR, 38(7), 2000, pp. 2726-2730
Authors:
Mouroux, M
Bossi, P
Yvon-Groussin, A
Delaugerre, C
Valantin, MA
Tubiana, R
Coutellier, A
Bonmarchand, M
Bricaire, F
Katlama, C
Agut, H
Huraux, JM
Calvez, V
Citation: M. Mouroux et al., Protease gene polymorphism in HIV-1-infected patients and response to therapy including a protease inhibitor., PATH BIOL, 47(5), 1999, pp. 549-552
Authors:
Bossi, P
Mouroux, M
Yvon, A
Bricaire, F
Agut, H
Huraux, JM
Katlama, C
Calvez, V
Citation: P. Bossi et al., Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor, J CLIN MICR, 37(9), 1999, pp. 2910-2912
Authors:
Bossi, P
Yvon, A
Mouroux, M
Huraux, JM
Agut, H
Calvez, V
Citation: P. Bossi et al., Mutations in the human immunodeficiency virus type 1 reverse transcriptasegene observed in stavudine and didanosine strains obtained by in vitro passages, RES VIROL, 149(6), 1998, pp. 355-361
Risultati:
1-10
|